nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal B-cell development in TIMP-deficient bone marrow
|
Weiss, Ashley |
|
|
5 |
20 |
p. 3960-3974 |
artikel |
2 |
Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia
|
Yu, Tian-shu |
|
|
5 |
20 |
p. 4087-4101 |
artikel |
3 |
Activation status dictates the function of unlicensed natural killer cells in mice and humans
|
Aguilar, Ethan G. |
|
|
5 |
20 |
p. 4219-4232 |
artikel |
4 |
Adoptive T-cell therapy for Hodgkin lymphoma
|
Ho, Carrie |
|
|
5 |
20 |
p. 4291-4302 |
artikel |
5 |
Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia
|
Rashidi, Armin |
|
|
5 |
20 |
p. 3937-3950 |
artikel |
6 |
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
|
Cuker, Adam |
|
|
5 |
20 |
p. 3951-3959 |
artikel |
7 |
A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia
|
Yu, Lei |
|
|
5 |
20 |
p. 4167-4178 |
artikel |
8 |
A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency
|
Fujii, Yoritaka |
|
|
5 |
20 |
p. 4265-4277 |
artikel |
9 |
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma
|
Ferrari, Nicola |
|
|
5 |
20 |
p. 4003-4016 |
artikel |
10 |
Anticoagulant therapy in patients with congenital FXI deficiency
|
Bravo-Pérez, Carlos |
|
|
5 |
20 |
p. 4083-4086 |
artikel |
11 |
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial
|
Fox, Christopher P. |
|
|
5 |
20 |
p. 4073-4082 |
artikel |
12 |
A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations
|
Jiang, Debbie |
|
|
5 |
20 |
p. 3931-3936 |
artikel |
13 |
Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study
|
Huang, Shih-Han Susan |
|
|
5 |
20 |
p. 4211-4218 |
artikel |
14 |
Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018
|
Goel, Ruchika |
|
|
5 |
20 |
p. 4179-4184 |
artikel |
15 |
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
|
Siddiqi, Tanya |
|
|
5 |
20 |
p. 4059-4063 |
artikel |
16 |
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
|
Wagner Jr, John E. |
|
|
5 |
20 |
p. 4064-4072 |
artikel |
17 |
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma
|
Neelapu, Sattva S. |
|
|
5 |
20 |
p. 4149-4155 |
artikel |
18 |
Editorial Board
|
|
|
|
5 |
20 |
p. i |
artikel |
19 |
Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
|
Imber, Brandon S. |
|
|
5 |
20 |
p. 4185-4197 |
artikel |
20 |
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition
|
Saito, Kaori |
|
|
5 |
20 |
p. 4233-4255 |
artikel |
21 |
Follicular lymphoma and macrophages: impact of approved and novel therapies
|
Gouni, Sushanth |
|
|
5 |
20 |
p. 4303-4312 |
artikel |
22 |
Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging
|
Abdelfattah, Ali |
|
|
5 |
20 |
p. 4285-4290 |
artikel |
23 |
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations
|
Koh, Jiwon |
|
|
5 |
20 |
p. 3919-3930 |
artikel |
24 |
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma
|
Bolomsky, Arnold |
|
|
5 |
20 |
p. 4125-4139 |
artikel |
25 |
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study
|
Ito, Ayumu |
|
|
5 |
20 |
p. 4156-4166 |
artikel |
26 |
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
|
Gangaraju, Radhika |
|
|
5 |
20 |
p. 4102-4111 |
artikel |
27 |
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
|
Samra, Bachar |
|
|
5 |
20 |
p. 3913-3918 |
artikel |
28 |
Multiparameter phenotyping of platelet reactivity for stratification of human cohorts
|
Dunster, Joanne L. |
|
|
5 |
20 |
p. 4017-4030 |
artikel |
29 |
Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
|
Miljkovic, Milos D. |
|
|
5 |
20 |
p. 4198-4210 |
artikel |
30 |
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
|
DeFilipp, Zachariah |
|
|
5 |
20 |
p. 4278-4284 |
artikel |
31 |
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
|
Lew, Thomas E. |
|
|
5 |
20 |
p. 4054-4058 |
artikel |
32 |
Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking
|
Buitrago, Lorena |
|
|
5 |
20 |
p. 3986-4002 |
artikel |
33 |
Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
|
Li, Na |
|
|
5 |
20 |
p. 4256-4264 |
artikel |
34 |
Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice
|
Goedhart, Tine M.H.J. |
|
|
5 |
20 |
p. 4314-4325 |
artikel |
35 |
Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
|
Bistervels, Ingrid M. |
|
|
5 |
20 |
p. 4044-4053 |
artikel |
36 |
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy
|
Patel, Anand Ashwin |
|
|
5 |
20 |
p. 4140-4148 |
artikel |
37 |
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling
|
Peña, Oscar A. |
|
|
5 |
20 |
p. 4112-4124 |
artikel |
38 |
Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury
|
Bayat, Behnaz |
|
|
5 |
20 |
p. 3975-3985 |
artikel |
39 |
Treatment of allosensitized patients receiving allogeneic transplantation
|
Ciurea, Stefan O. |
|
|
5 |
20 |
p. 4031-4043 |
artikel |
40 |
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
|
Arruda, Valder R. |
|
|
5 |
20 |
p. 4313 |
artikel |